Lifevantage Price to Sales Ratio 2010-2023 | LFVN
Historical PS ratio values for Lifevantage (LFVN) over the last 10 years. The current P/S ratio for Lifevantage as of May 01, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Lifevantage P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-05-01 |
6.18 |
|
0.37 |
| 2023-12-31 |
5.97 |
$16.53 |
0.36 |
| 2023-09-30 |
6.38 |
$16.72 |
0.38 |
| 2023-06-30 |
4.04 |
$16.94 |
0.24 |
| 2023-03-31 |
3.31 |
$16.53 |
0.20 |
| 2022-12-31 |
3.40 |
$16.09 |
0.21 |
| 2022-09-30 |
3.40 |
$15.74 |
0.22 |
| 2022-06-30 |
3.92 |
$15.55 |
0.25 |
| 2022-03-31 |
4.26 |
$15.49 |
0.27 |
| 2021-12-31 |
5.65 |
$15.35 |
0.37 |
| 2021-09-30 |
6.05 |
$15.51 |
0.39 |
| 2021-06-30 |
6.57 |
$15.29 |
0.43 |
| 2021-03-31 |
8.36 |
$15.51 |
0.54 |
| 2020-12-31 |
8.33 |
$15.70 |
0.53 |
| 2020-09-30 |
10.79 |
$15.82 |
0.68 |
| 2020-06-30 |
12.09 |
$15.81 |
0.76 |
| 2020-03-31 |
9.21 |
$15.50 |
0.59 |
| 2019-12-31 |
13.96 |
$15.34 |
0.91 |
| 2019-09-30 |
12.25 |
$15.02 |
0.82 |
| 2019-06-30 |
11.60 |
$14.97 |
0.77 |
| 2019-03-31 |
12.78 |
$15.05 |
0.85 |
| 2018-12-31 |
11.79 |
$14.95 |
0.79 |
| 2018-09-30 |
9.82 |
$14.56 |
0.67 |
| 2018-06-30 |
5.69 |
$14.37 |
0.40 |
| 2018-03-31 |
3.23 |
$14.14 |
0.23 |
| 2017-12-31 |
4.26 |
$13.76 |
0.31 |
| 2017-09-30 |
3.77 |
$13.73 |
0.27 |
| 2017-06-30 |
3.87 |
$14.04 |
0.28 |
| 2017-03-31 |
4.80 |
$14.10 |
0.34 |
| 2016-12-31 |
7.29 |
$14.88 |
0.49 |
| 2016-09-30 |
8.46 |
$15.13 |
0.56 |
| 2016-06-30 |
12.16 |
$14.61 |
0.83 |
| 2016-03-31 |
8.14 |
$14.17 |
0.57 |
| 2015-12-31 |
8.51 |
$13.42 |
0.63 |
| 2015-09-30 |
5.07 |
$13.07 |
0.39 |
| 2015-06-30 |
3.32 |
$13.27 |
0.25 |
| 2015-03-31 |
4.94 |
$13.58 |
0.36 |
| 2014-12-31 |
8.14 |
$13.96 |
0.58 |
| 2014-09-30 |
7.13 |
$13.82 |
0.52 |
| 2014-06-30 |
9.01 |
$13.25 |
0.68 |
| 2014-03-31 |
8.20 |
$12.67 |
0.65 |
| 2013-12-31 |
10.33 |
$11.87 |
0.87 |
| 2013-09-30 |
14.89 |
$11.60 |
1.28 |
| 2013-06-30 |
14.52 |
$11.64 |
1.25 |
| 2013-03-31 |
14.71 |
$11.34 |
1.30 |
| 2012-12-31 |
13.70 |
$10.98 |
1.25 |
| 2012-09-30 |
21.46 |
$9.50 |
2.26 |
| 2012-06-30 |
17.71 |
$7.71 |
2.30 |
| 2012-03-31 |
23.53 |
$6.31 |
3.73 |
| 2011-12-31 |
8.95 |
$4.81 |
1.86 |
| 2011-09-30 |
9.39 |
$3.92 |
2.39 |
| 2011-06-30 |
9.39 |
$3.27 |
2.87 |
| 2011-03-31 |
4.44 |
$2.55 |
1.74 |
| 2010-12-31 |
2.44 |
$1.93 |
1.27 |
| 2010-09-30 |
3.13 |
$1.66 |
1.89 |
| 2010-06-30 |
3.19 |
$1.39 |
2.29 |
| 2010-03-31 |
2.44 |
$1.11 |
2.20 |
| 2009-12-31 |
1.56 |
$0.95 |
1.64 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.079B |
$0.213B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
